12 results on '"R. Fietkau"'
Search Results
2. [Nutrition of ENT tumor patients treated with radiotherapy. Comparison of oral and enteral nutrition using percutaneous gastrostomy]
- Author
-
H, Iro, R, Fietkau, S, Kolb, and N, Nitsche
- Subjects
Gastrostomy ,Oropharyngeal Neoplasms ,Otorhinolaryngologic Neoplasms ,Skinfold Thickness ,Enteral Nutrition ,Hypopharyngeal Neoplasms ,Carcinoma, Squamous Cell ,Quality of Life ,Humans ,Mouth Neoplasms ,Prospective Studies ,Combined Modality Therapy ,Body Mass Index - Abstract
The nutritional state of 99 patients with head and neck malignancies was assessed before, during and up to 18 weeks after radiotherapy (DXRT) using anthropometry, immunology and blood chemistry. 73 patients were fed orally during therapy, first with a normal diet and later, when the side effects of DXRT worsened, with a supplemental liquid formula diet. During the first two weeks 26 patients were treated with a PEG (percutaneous endoscopically controlled gastrostomy) and were fed mainly enterally with formula diets. The parameters of those patients fed orally during DXRT worsened rapidly and only recovered slowly and incompletely. On the contrary, in spite of their poor initial condition, the patients with PEG improved their state of nutrition, even during DXRT. Both the objective parameters of nutrition and the subjective condition of the patients were measured with the help of the "quality of life index". During DXRT the quality of life of both groups deteriorated equally. The objective parameters of nutrition showed that the patient's strength and the capacity for work remained constant. Unexpectedly, after DXRT only the orally fed patients were found to have an improved subjective condition, probably because the PEG patients were reminded of their disease by the tube, in spite of successful completion of tumor therapy. This undoubtedly impedes the return to normal family and working life. Early and consistent enteral diet with PEG helps to stabilize the state of nutrition of patients with head and neck cancer, and is recommended, especially for patients already suffering from malnutrition before starting an aggressive multimodal tumor therapy.
- Published
- 1989
3. [Experiences with percutaneous endoscopy controlled gastrostomy in patients with neck and otolaryngologic tumors]
- Author
-
H, Iro, H G, Kachlik, R, Fietkau, H J, Thiel, and S, Kolb
- Subjects
Gastrostomy ,Oropharyngeal Neoplasms ,Enteral Nutrition ,Hypopharyngeal Neoplasms ,Head and Neck Neoplasms ,Humans ,Endoscopy ,Mouth Neoplasms ,Laryngeal Neoplasms - Abstract
Most patients with head and neck tumours need supportive long-term nutrition. To guarantee enteral food intake we implanted a nasogastric tube percutaneously without any complications in 108 patients. The advantage of this method of feeding is that the direct percutaneous route avoids any mechanical irritation of the upper gastro-intestinal tract; this could be important, for example, during radiotherapy, because the mucous membranes are already damaged. In addition the gastric tube is invisible below the patient's clothing so that he can move about without embarrassment.
- Published
- 1988
4. [DNA impulse cytophotometry measurements in head and neck tumors. Initial results of a correlation with clinical stage, therapeutic response and pattern of recurrence]
- Author
-
R, Fietkau, H, Iro, P, Bilek, and R, Sauer
- Subjects
Male ,Ploidies ,Head and Neck Neoplasms ,Lymphatic Metastasis ,Humans ,Female ,DNA, Neoplasm ,Lymph Nodes ,Neoplasm Recurrence, Local ,Flow Cytometry ,Prognosis ,Interphase ,Neoplasm Staging - Abstract
The DNA index and proliferation rate (percentage of S-phase cells) of 52 head and neck tumours were analysed by flow cytometry. Thirty-one (60%) of these tumours were aneuploid, 21 (40%) diploid. The distribution of aneuploid tumours was nearly equal in all T-stages. In contrast, the number of aneuploid tumours increased with higher N-stages. Locoregional recurrences developed more often (69%) in aneuploid tumours than in diploid tumours (54%). Furthermore, recurrence presented earlier (median 5 months) than in the latter (median 11 months). Regional recurrences were mainly observed in aneuploid tumours, local recurrences in diploid tumours.
- Published
- 1989
5. [Highlights from the 2021 ASCO and ESMO annual meetings on radiotherapy of head and neck cancer].
- Author
-
Hecht M, von der Grün J, Semrau S, Müller S, Weissmann T, Gaipl US, Iro H, Fietkau R, and Gostian AO
- Subjects
- Chemoradiotherapy methods, Humans, Immunotherapy, Medical Oncology, Head and Neck Neoplasms therapy, Oropharyngeal Neoplasms radiotherapy
- Abstract
At this year's annual meetings of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), several studies on radiotherapy of locally advanced head and neck cancer were presented. For the indication of definitive radiochemotherapy, particularly the administration of immune checkpoint inhibitors concomitant to radiotherapy was investigated. In the phase III GORTEC-REACH trial, combined inhibition of epidermal growth factor receptor (EGFR) and programmed death-ligand (PD-L1) concomitant to radiotherapy of locally advanced head and neck cancer was inferior to platinum-based chemoradiotherapy. However, this therapeutic approach may be more efficient than radiotherapy with simultaneous EGFR inhibition alone. The concept of the phase II CheckRad-CD8 trial with induction chemoimmunotherapy followed by chemotherapy-free radioimmunotherapy after appropriate patient selection also proved to be highly efficient. In initial phase II trials, dose de-escalation of radiotherapy seems feasible for HPV-positive oropharyngeal cancer after appropriate patient selection both postoperatively (ECOG-ACRIN E3311 trial) and after induction therapy (Optima II trial). However, dose de-escalation should currently not be performed outside of clinical trials. In addition, first studies indicate a benefit of functional imaging (diffusion-weighted magnetic resonance imaging [MRI] or F‑fluoromisonidazole positron-emission tomography [FMISO-PET]) to establish personalized dose concepts in radiotherapy., (© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
6. [Low-grade (polymorphous) adenocarcinoma of the middle ear mimicking a jugulotympanic paraganglioma. German version].
- Author
-
Mantsopoulos K, Taha L, Fietkau R, Hornung J, Agaimy A, and Iro H
- Subjects
- Ear, Middle diagnostic imaging, Ear, Middle pathology, Female, Humans, Magnetic Resonance Imaging, Middle Aged, Petrous Bone, Adenocarcinoma pathology, Glomus Jugulare Tumor diagnosis, Glomus Jugulare Tumor surgery
- Abstract
A 64-year-old female patient presented with otalgia and hearing loss in the right ear. On otoscopy, the right tympanic membrane was highly vascularized and bulged into the anteroinferior quadrant. High-resolution computed tomography revealed an osteolytic lesion with occupation of the hypotympanum extending into the petrous apex and right parapharyngeal space as well as infiltration of the wall of the right internal carotid artery. MRI strengthened the suspicion of a jugulotympanic paraganglioma. The biopsy material obtained through exploratory tympanotomy was assessed as a low-grade polymorphic adenocarcinoma. The tumor was treated with definitive chemoradiotherapy. Posttherapeutic imaging after 4 months did not show any evidence of tumor progression., (© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
7. Low-grade (polymorphous) adenocarcinoma of the middle ear mimicking a jugulotympanic paraganglioma.
- Author
-
Mantsopoulos K, Taha L, Fietkau R, Hornung J, Agaimy A, and Iro H
- Subjects
- Ear, Middle diagnostic imaging, Female, Humans, Magnetic Resonance Imaging, Middle Aged, Petrous Bone, Adenocarcinoma, Glomus Jugulare Tumor diagnosis, Paraganglioma
- Abstract
A 64-year-old female patient presented with otalgia and hearing loss in the right ear. On otoscopy, the right tympanic membrane was highly vascularized and bulged into the anteroinferior quadrant. High-resolution computed tomography revealed an osteolytic lesion with occupation of the hypotympanum extending into the petrous apex and right parapharyngeal space as well as infiltration of the wall of the right internal carotid artery. MRI strengthened the suspicion of a jugulotympanic paraganglioma. The biopsy material obtained through exploratory tympanotomy was assessed as a low-grade polymorphic adenocarcinoma. The tumor was treated with definitive chemoradiotherapy. Posttherapeutic imaging after 4 months did not show any evidence of tumor progression., (© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
8. [Therapy of malignant tumors in the area of the paranasal sinuses].
- Author
-
Hosemann W, Dammer R, Bloss HG, and Fietkau R
- Subjects
- Adenocarcinoma mortality, Adenocarcinoma pathology, Adenocarcinoma radiotherapy, Adenocarcinoma surgery, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell surgery, Combined Modality Therapy, Humans, Neoplasm Staging, Paranasal Sinus Neoplasms mortality, Paranasal Sinus Neoplasms pathology, Paranasal Sinus Neoplasms radiotherapy, Radiotherapy, Adjuvant, Survival Rate, Paranasal Sinus Neoplasms surgery
- Published
- 2002
- Full Text
- View/download PDF
9. [Therapy of hypopharyngeal cancer. Part IV: Long-term results of transoral laser microsurgery of hypopharyngeal cancer].
- Author
-
Steiner W, Stenglein C, Fietkau R, and Sauerbrei W
- Subjects
- Adult, Aged, Carcinoma mortality, Carcinoma pathology, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Hypopharyngeal Neoplasms mortality, Hypopharyngeal Neoplasms pathology, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Palliative Care, Survival Rate, Carcinoma surgery, Carcinoma, Squamous Cell surgery, Hypopharyngeal Neoplasms surgery, Laser Therapy, Microsurgery, Neoplasm Recurrence, Local surgery
- Abstract
Between 1979 and 1986, 74 patients with hypopharyngeal carcinomas were operated using transoral laser microsurgery by the first author. 32 of the patients were subdivided into 5 subgroups and considered separately because of pretreatment for head and neck tumors, simultaneous multiple tumors etc. (excluding criterias). Survival times were not significantly prolonged and lasted 1-27 months (median, 11 months), but the quality of life was improved due to preservation or restoration of natural laryngopharyngeal functions. Forty-two patients were operated with curative intention. This group primarily underwent transoral laser microsurgery, aiming at complete locoregional tumor resection with function preservation (pT1, 5; pT2, 31; pT3, 4; pT4, 2). In 29 patients 31 necks were operated, mostly as a regionally limited functional neck dissection (or "selective" neck dissection). In 90% of the cases neck metastases (pN+) were found, mostly in levels II and III; pN1, 6; pN2a, 1; pN2b, 18; pN2c, 1. Altogether, stages III and IV were found in 71.4% of the patients. A temporary tracheotomy was required in four patients. There was no secondary laryngectomy, even though it was indicated in one case. Post-treatment oncological followup (median observation time, 104 months) demonstrated loco-regional recurrences (n = 1), late or recurrent metastases (n = 4), persisting metastases in the neck with cerebral metastasis (n = 1), distant metastases (n = 4), secondary tumors (n = 9, 5 of which occurred in the head and neck). Through March 1993, 24 patients (57%) have died. Causes were TNM-related (7), second primary tumor with or without distant metastases (8) and intercurrent disease with no evidence of disease (9). Within 5 years 17% of the patients died of TNM-related tumors, 9.5% due to a second primary with or without distant metastases, as well as 9.5% with intercurrent disease. The 5-year overall survival rate was 64% and was 83% (adjusted survival rate) if only TNM-related deaths were considered.
- Published
- 1994
10. [Experiences with percutaneous endoscopy controlled gastrostomy in patients with neck and otolaryngologic tumors].
- Author
-
Iro H, Kachlik HG, Fietkau R, Thiel HJ, and Kolb S
- Subjects
- Endoscopy, Humans, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Enteral Nutrition instrumentation, Gastrostomy methods, Head and Neck Neoplasms
- Abstract
Most patients with head and neck tumours need supportive long-term nutrition. To guarantee enteral food intake we implanted a nasogastric tube percutaneously without any complications in 108 patients. The advantage of this method of feeding is that the direct percutaneous route avoids any mechanical irritation of the upper gastro-intestinal tract; this could be important, for example, during radiotherapy, because the mucous membranes are already damaged. In addition the gastric tube is invisible below the patient's clothing so that he can move about without embarrassment.
- Published
- 1988
11. [Nutrition of ENT tumor patients treated with radiotherapy. Comparison of oral and enteral nutrition using percutaneous gastrostomy].
- Author
-
Iro H, Fietkau R, Kolb S, and Nitsche N
- Subjects
- Body Mass Index, Combined Modality Therapy, Humans, Hypopharyngeal Neoplasms radiotherapy, Mouth Neoplasms radiotherapy, Oropharyngeal Neoplasms radiotherapy, Prospective Studies, Quality of Life, Skinfold Thickness, Carcinoma, Squamous Cell radiotherapy, Enteral Nutrition instrumentation, Gastrostomy instrumentation, Otorhinolaryngologic Neoplasms radiotherapy
- Abstract
The nutritional state of 99 patients with head and neck malignancies was assessed before, during and up to 18 weeks after radiotherapy (DXRT) using anthropometry, immunology and blood chemistry. 73 patients were fed orally during therapy, first with a normal diet and later, when the side effects of DXRT worsened, with a supplemental liquid formula diet. During the first two weeks 26 patients were treated with a PEG (percutaneous endoscopically controlled gastrostomy) and were fed mainly enterally with formula diets. The parameters of those patients fed orally during DXRT worsened rapidly and only recovered slowly and incompletely. On the contrary, in spite of their poor initial condition, the patients with PEG improved their state of nutrition, even during DXRT. Both the objective parameters of nutrition and the subjective condition of the patients were measured with the help of the "quality of life index". During DXRT the quality of life of both groups deteriorated equally. The objective parameters of nutrition showed that the patient's strength and the capacity for work remained constant. Unexpectedly, after DXRT only the orally fed patients were found to have an improved subjective condition, probably because the PEG patients were reminded of their disease by the tube, in spite of successful completion of tumor therapy. This undoubtedly impedes the return to normal family and working life. Early and consistent enteral diet with PEG helps to stabilize the state of nutrition of patients with head and neck cancer, and is recommended, especially for patients already suffering from malnutrition before starting an aggressive multimodal tumor therapy.
- Published
- 1989
12. [DNA impulse cytophotometry measurements in head and neck tumors. Initial results of a correlation with clinical stage, therapeutic response and pattern of recurrence].
- Author
-
Fietkau R, Iro H, Bilek P, and Sauer R
- Subjects
- Female, Flow Cytometry, Head and Neck Neoplasms surgery, Humans, Interphase, Lymph Nodes pathology, Lymphatic Metastasis, Male, Neoplasm Staging, Ploidies, Prognosis, DNA, Neoplasm analysis, Head and Neck Neoplasms pathology, Neoplasm Recurrence, Local pathology
- Abstract
The DNA index and proliferation rate (percentage of S-phase cells) of 52 head and neck tumours were analysed by flow cytometry. Thirty-one (60%) of these tumours were aneuploid, 21 (40%) diploid. The distribution of aneuploid tumours was nearly equal in all T-stages. In contrast, the number of aneuploid tumours increased with higher N-stages. Locoregional recurrences developed more often (69%) in aneuploid tumours than in diploid tumours (54%). Furthermore, recurrence presented earlier (median 5 months) than in the latter (median 11 months). Regional recurrences were mainly observed in aneuploid tumours, local recurrences in diploid tumours.
- Published
- 1989
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.